Targeting TRIP13 in Wilms Tumor with Nuclear Export Inhibitors is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2022). On theSindex it has a DataRank of 0.269. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 5T32GM008490-17
Predoctoral Training Program in Genetics
National Institutes of Health
Grant: 5U01CA176058-09
The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center
National Institutes of Health
Grant: 5P30CA138292-11
Winship Cancer Institute Cancer Center Support Grant
National Institutes of Health
Grant: 5T32GM007739-30
Weill Cornell/Rockefeller/Sloan-Kettering MST Program
National Institutes of Health
Grant: 5R35CA231958-03
Targeting High-Risk Lymphoid Neoplasms
Fields of Study
Sustainable Development Goals